Daiichi Sankyo Company (DSKYF) Receives a Buy from Bernstein
Bernstein analyst Miki Sogi maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) yesterday and set a price target of Yen6,400.00.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Sogi is an analyst with an average return of -1.9% and a 45.45% success rate. Sogi covers the Healthcare sector, focusing on stocks such as Daiichi Sankyo Company, Astellas Pharma, and Chugai Pharmaceutical Co.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Daiichi Sankyo Company with a $40.43 average price target.
The company has a one-year high of $44.64 and a one-year low of $20.15. Currently, Daiichi Sankyo Company has an average volume of 76.67K.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
42 minutes ago
- Business Insider
CFRA upgrades Dollar General (DG) to a Hold
In a report released today, Arun Sundaram from CFRA upgraded Dollar General (DG – Research Report) to a Hold, with a price target of $118.00. The company's shares closed today at $112.57. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Sundaram is a 3-star analyst with an average return of 8.0% and a 63.16% success rate. Dollar General has an analyst consensus of Moderate Buy, with a price target consensus of $97.20, representing a -13.65% downside. In a report released today, Telsey Advisory also initiated coverage with a Hold rating on the stock with a $100.00 price target. Based on Dollar General's latest earnings release for the quarter ending January 31, the company reported a quarterly revenue of $10.3 billion and a net profit of $191.22 million. In comparison, last year the company earned a revenue of $9.86 billion and had a net profit of $401.81 million Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DG in relation to earlier this year. Most recently, in April 2025, EMILY C TAYLOR, the EVP & Chief Merchandising Ofc of DG sold 809.00 shares for a total of $76,620.39.
Business Insider
42 minutes ago
- Business Insider
William Blair Reaffirms Their Buy Rating on LENZ Therapeutics (LENZ)
William Blair analyst Lachlan Hanbury Brown maintained a Buy rating on LENZ Therapeutics (LENZ – Research Report) today. The company's shares closed today at $29.77. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Hanbury Brown is a 3-star analyst with an average return of 6.2% and a 60.00% success rate. Hanbury Brown covers the Healthcare sector, focusing on stocks such as ARS Pharmaceuticals, Apellis Pharmaceuticals, and LENZ Therapeutics. Currently, the analyst consensus on LENZ Therapeutics is a Strong Buy with an average price target of $47.43.
Business Insider
an hour ago
- Business Insider
Pagaya president Das sells 31,382 class A ordinary shares
In a regulatory filing, Pagaya (PGY) president Sanjiv Das disclosed the sale of 31,382 class A ordinary shares of the company on June 3 at a price of $17.15 per share. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
